Caxton Associates (New York)’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,873
| Closed | -$1.6M | – | 602 |
|
|
2024
Q2 | $1.6M | Sell |
3,873
-94
| -2% | -$38.7K | 0.05% | 186 |
|
|
2024
Q1 | $1.6M | Buy |
3,967
+2,840
| +252% | +$1.15M | 0.09% | 155 |
|
|
2023
Q4 | $345K | Buy |
+1,127
| New | +$345K | 0.02% | 378 |
|
|
2023
Q2 | – | Sell |
-1,911
| Closed | -$359K | – | 590 |
|
|
2023
Q1 | $359K | Buy |
+1,911
| New | +$359K | 0.05% | 318 |
|
|
2022
Q1 | – | Sell |
-2,858
| Closed | -$622K | – | 600 |
|
|
2021
Q4 | $622K | Buy |
2,858
+1,735
| +154% | +$378K | 0.06% | 199 |
|
|
2021
Q3 | $213K | Sell |
1,123
-1,678
| -60% | -$318K | 0.02% | 367 |
|
|
2021
Q2 | $495K | Buy |
2,801
+1,128
| +67% | +$199K | 0.05% | 156 |
|
|
2021
Q1 | $274K | Buy |
+1,673
| New | +$274K | 0.02% | 280 |
|
|
2020
Q4 | – | Sell |
-5,171
| Closed | -$578K | – | 229 |
|
|
2020
Q3 | $578K | Sell |
5,171
-1,447
| -22% | -$162K | 0.06% | 92 |
|
|
2020
Q2 | $616K | Buy |
+6,618
| New | +$616K | 0.05% | 93 |
|
|
2019
Q2 | – | Sell |
-4,714
| Closed | -$278K | – | 465 |
|
|
2019
Q1 | $278K | Buy |
+4,714
| New | +$278K | 0.04% | 269 |
|
|
2018
Q4 | – | Sell |
-11,113
| Closed | -$666K | – | 384 |
|
|
2018
Q3 | $666K | Buy |
11,113
+6,182
| +125% | +$370K | 0.05% | 147 |
|
|
2018
Q2 | $212K | Buy |
+4,931
| New | +$212K | 0.01% | 306 |
|